Table 2.
Characteristics of patients with COVID-19 symptoms.
| Variable | N = 296 |
|---|---|
| Time elapsed from the onset of symptoms to | 3 days (1–4) |
| consultation, median (IQR) | |
| Principal diagnosis on admission, n (%) | |
| Upper-respiratory infection due to COVID-19 | 176 (60) |
| Lower-respiratory infection due to COVID-19 | 33 (11) |
| Bronchiolitis | 16 (48) |
| Pneumonia | 17 (52) |
| Acute gastroenteritis | 18 (6) |
| Asthma | 15 (5) |
| Neurological (epilepsy, seizures, hydrocephaly) | 10 (4) |
| Sepsis | 9 (3) |
| Urinary tract infection | 7 (2) |
| MIS-C | 4 (1) |
| Othersa | 24 (8) |
| Symptoms or signs present on admissions, n (%) | |
| Fever | 178 (60) |
| Rhinorrhea/nasal congestion | 164 (55) |
| Cough | 149 (50) |
| General malaise | 75 (25) |
| Gastrointestinal symptoms | 74 (25) |
| Respiratory distress syndrome | 42 (14) |
| Odynophagia | 32 (11) |
| Headache | 24 (8) |
| Stridor | 11 (4) |
| Rash | 9 (3) |
| Hypoxemia | 8 (3) |
| Seizure | 6 (2) |
| Apnea | 5 (2) |
| Ageusia | 5 (2) |
| Anosmia | 4 (1) |
| Comorbidities, n (%) | |
| None | 225 (76) |
| Asthma | 25 (8) |
| Chronic lung disease | 15 (5) |
| Immunosuppression / immunodeficiency | 14 (5) |
| Hemato-oncological disease | 9 (3) |
| Othersb | 8 (3) |
| Chest x-ray, n (%) | N = 145 |
| Normal | 73 (50) |
| Interstitial pattern | 42 (29) |
| Alveolar opacity | 17 (12) |
| Atelectasis | 8 (6) |
| Othersc | 5 (3) |
| Positive first test, n (%) | 271 (91) |
| PCR | 267 (99) |
| Antigen | 4 (1) |
| Positive second test (RT-PCR), n (%) | 27 (9) |
| Positive IgM serology, n (%) | 1 (0.3) |
| Complications, n (%) | 17 (6) |
| Coinfection, n (%) | 44 (15) |
| Viral | 20 (48) |
| Bacterial | 22 (52) |
| Hospitalization, n (%) | 157 (53) |
| Admission to intensive care, n (%) | 24 (8) |
| Hospital stay, median (IQR) | 2 days (1–3) |
IgM, immunoglobulin M; MIS-C, Multi-system inflammatory syndrome in children. a Others: BRUE, trauma, arterial hypertension, appendicitis, bone marrow aplasia, acute myeloid leukemia, bacteremia, tachycardia, malnutrition, cystic fibrosis, mononucleosis, syncope, sickle cell anemia, sexual abuse, osteomyelitis. b Others: pulmonary hypertension 3 patients, arterial hypertension 2 patients, obesity 2 patients, biological therapy 1 patient. c Others: hyperinflation 3 patients, pleural effusion 1 patient, ground glass 1 patient.